Kotak Mahindra Bank Announces Key Leadership Appointments
Bengaluru, February 21, 2025 – Kotak Mahindra Bank today announced the appointments of Vyomesh Kapasi as the new Head of Products – Consumer Bank at Kotak Mahindra Bank and Shahrukh Todiwala as the new MD & CEO of Kotak Mahindra Prime Limited (KMPL).
Announcing the changes, Ashok Vaswani, MD & CEO of Kotak Mahindra Bank, said, “These appointments underscore the deep bench strength at Kotak and our commitment to fostering leadership talent. Vyomesh’s extensive experience and proven track record in driving growth and innovation will be invaluable as we continue to enhance our consumer products. Shahrukh’s deep understanding of the vehicle financing market will ensure that KMPL continues to thrive and deliver exceptional value to our clients and stakeholders.”
Vyomesh joins Kotak Mahindra Bank from KMPL, where he served as the MD & CEO and led the company to new heights. With over three decades of experience in the financial sector, Vyomesh brings a wealth of knowledge and expertise to his new role.
Shahrukh Todiwala takes over from Vyomesh Kapasi as the new MD & CEO of Kotak Mahindra Prime Limited. Shahrukh has been with KMPL since 1995, and currently heads Wholesale and Retail vehicle finance businesses at KMPL. He has played a key role in the company’s strategic initiatives and has a deep understanding of the vehicle financing market.
BioAsia 2025 to Gather Global Healthcare Leaders for Innovation
Hyderabad: 21th February, 2025: Bio Asia, Asia’s premier life sciences and Health Tech forum, has a lineup of inspirational speakers and industry luminaries to ignite a discussion with participating leaders, MSME’s and startups to inspire and make India an undisputed leaderin the Life Sciences space. With the impressive lineup of speakers, Bio Asia 2025 is all set to act as a ‘Catalyst of Change’ driving rapid transformation in the life sciences space.
A power packed agenda comprising of address from Mr. A Revanth Reddy, Hon’ble CM of Telangana, Dr. Jeannette Young, Hon’ble Governor of Queensland,Mr. Amitabh Kant, G20 Sherpa, Mr. Piyush Goyal, Hon’ble Minister of Industry and Supplies, Govt. of India, besides the global Industry leaders will be the highlight of Bio Asia 2025.
Notable industry leaders from the leading global organizations likeRobert A. Bradway (Chairman & CEO, Amgen), Prof. Patrick Tan, (Executive Director, Genome Institute of Singapore), Dr. Ken Washington (CTO, Medtronic), Dr. Boris Stoffel (Managing Director, Miltenyi Biotec) along with leaders from other global healthcare organizations will participate across 8 sessions scheduled on 25th and 26th February 2025. A detailed schedule for Bio Asia 2025 can be accessed here.
The CEO Conclave scheduled on 25th February 2025 will have eminent speakers Dr. S. Somanath, Former Chairman, ISRO, Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories, Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech International Ltd,Dr. Satyanarayana Chava, Founder and CEO, Laurus Labs, Mr. Cesar Concepcion, Chief Commercial Officer, APMA region, Novartis and Mr. Winselow Tucker, President and General Manager, Lilly India who will discuss the key opportunities and challenges for the life sciences in Indian and overseas markets and the disruptive role India can adopt to lead the global life sciences space with emerging technology innovations.
BioAsia 2025 is set to be a landmark event for the life sciences and healthcare industry. As a hub for global healthcare innovations, Telangana has become a key player in driving medical research, biotechnology, and pharmaceutical excellence. BioAsia will continue its tradition of showcasing Telangana’s leadership in fostering industry growth, collaboration, and cutting-edge research while positioning the state as a key destination for global life sciences investments.
Mr. Sridhar Babu, Minister for Industries and Commerce, Government of Telangana, expressed his enthusiasm about the distinguished lineup of guests at BioAsia 2025, stating: “BioAsia 2025 marks the 22nd edition of Asia’s leading life sciences and healthcare forum, bringing together global leaders to discuss AI-driven healthcare transformation, innovations in life sciences, data interoperability, and India’s potential in clinical trials. I am personally thrilled with the depth of this year’s program and the exceptional speaker lineup, with a strong focus on AI and life sciences. I am confident that this will be the biggest and most impactful BioAsia in history.”
Mr. Jayesh Ranjan IAS, Special Chief Secretary, Industries & Commerce and Information Technology, Government of Telangana, said: “The diverse lineup of speakers at BioAsia 2025 will further establish it as a premier platform for knowledge exchange and future-shaping discussions. This year, organizations like Deloitte, BCG, EY-Parthenon, and HealthArk have partnered with BioAsia to curate the program alongside our industry partners and sponsors, driving meaningful conversations on the future of healthcare and life sciences. I am also pleased to see significant participation from startups, and the overall enthusiasm for the event has been truly phenomenal.”
Mr. Shakthi Nagappan, CEO of BioAsia and Director of Telangana Life Sciences, emphasized”India has immense potential to lead the convergence of life sciences and technology, and Telangana continues to be at the forefront of this transformation. BioAsia 2025 is set to be a landmark edition with several global leaders like the CEO of Amgen, CIO of MSD, etc participating in the event. We are particularly excited to welcome thought leaders like Dr. S. Somanath, whose expertise in space sciences and engineering brings a fresh perspective and inspire new approaches to tackling some of the most pressing challenges in life sciences.”
Bio Asia 2025 will feature high-impact sessions, panel discussions, and networking opportunities, engaging thought leaders, policymakers, and innovators to explore solutions for global healthcare challengesThe event will also highlight cutting-edge advancements in AI-driven healthcare, clinical research, and personalized medicine.
With India emerging as a key player in global healthcare and biotechnology, Bio Asia 2025 will provide an unparalleled platform for collaborations, knowledge sharing, and investment opportunities. The event will continue to strengthen Hyderabad’s position as a hub for life sciences innovation, reinforcing its contribution to the global healthcare ecosystem.
Lumaè Revolutionizes Skincare with Science-Backed Innovation
Delhi, 21th February, 2025: The beauty and skincare industry is set for a transformation with the grand launch of Lumaè, a brand dedicated to high-quality skincare solutions that prioritize skin health. Founded on efficacy, sustainability, and inclusivity, Lumaè redefines skincare with meticulously crafted formulations and a commitment to transparency.
Lumaè is the brainchild of siblings Gunjan Sharma and Shan Sharma, who share a vision of making high-performance skincare accessible to everyone, regardless of skin tone or gender. The brand’s journey began in 2020 as Daisybloom, a homemade skincare company driven by a passion for natural and effective solutions. As demand grew, the brand evolved into Lumaè, embracing the same core values with enhanced rigour and commitment. Inspired by the Latin word for “light,” Lumaè seeks to help individuals reveal their natural glow.
The brand’s launch collection introduces two standout products designed to effectively address major skin concerns, including acne and ageing. Lumaè unveils an anti-ageing night cream infused with Astaxanthin, a 6000x stronger antioxidant than Vitamin C, boosting collagen, reducing wrinkles, and enhancing elasticity. A first in Indian skincare, Astaxanthin was previously available only in supplements. Additionally, Lumaè’s anti-acne serum fights bacteria, controls oil, unclogs pores, and fades dark spots with Saffron, Ashwagandha, Salicylic & Glycolic Acid, ensuring clearer, brighter skin. Expanding its skincare linueup, Lumae’s skincare range now offers targeted solutions like nourishing night creams and effective anti-acne treatments, ensuring complete care for the skin.
Lumaè remains focused on providing customers with premium, high-quality ingredients that promote true skin health. All the products by Lumaè are designed for visible and lasting results and each formulation undergoes rigorous independent lab testing to ensure efficacy and safety, free from harsh chemicals.
One of Lumaè’s core values is transparency, and the brand is committed to educating customers about its ingredients and their benefits. By empowering consumers with knowledge, the brand ensures they make informed choices about their skincare. Meanwhile, sustainability is integral to Lumaè, with responsibly sourced ingredients such as astaxanthin, one of the most potent and sustainable skincare actives. The brand’s reusable and recyclable packaging further reinforces its commitment to a greener future.
Gunjan Sharma, Co-founder of Lumaè, shares, “What started as a personal passion project quickly evolved into something much bigger. We saw a real gap in the market for skincare that goes beyond just looking good. Our mission was to create products that genuinely improve skin health. With Lumaè, we have poured years of research and passion into crafting formulations that are safe, effective, and sustainable. We are excited to bring this vision to life. We also plan to expand our product line to address more skincare concerns so that everyone feels confident in their own skin.”
Shan Sharma, Co-founder of Lumaè, adds, “We believe that skincare should be inclusive, effective, and transparent. Our commitment is to ensure that everyone, regardless of skin tone or gender, has access to high-quality skincare that truly works. Sustainability is also at the core of what we do, from responsibly sourced ingredients to eco-friendly packaging, we are determined to make a difference. This is just the beginning, and we can’t wait to continue innovating and expanding our range to address even more skincare concerns.”
All Lumaè products are vegan, cruelty-free, proudly made in India with locally sourced ingredients, 100% natural and free from sulphates, parabens, and harsh chemicals. The formulations have been dermatologically tested by independent labs, ensuring they are safe for all skin types, including sensitive skin. Lumaè products are now available for purchase on the brand’s official online store.
Shiv Nadar Foundation and Illinois Tech Announce New Scholarship for Indian Students
21th February, Delhi: Shiv Nadar Foundation and Illinois Institute of Technology (Illinois Tech), Chicago, have signed a Memorandum of Understanding to establish a scholarship that will provide driven students from VidyaGyan School, a philanthropic initiative of the Shiv Nadar Foundation, with access to high-quality undergraduate education at Illinois Tech. This partnership underscores both institutions’ commitment to transforming the lives of students from all walks of life through education and building a more equitable global academic community.
VidyaGyan nurtures academically exceptional students from rural areas bringing them together at VidyaGyan to offer free access to quality residential middle and high school programs, empowering them to become future leaders. Under this new collaboration, two VidyaGyan graduates—Raj Dwivedi and Vijay Pratap Singh—have already joined Illinois Tech as first-year students, making them the first in their district in India to pursue higher education in the United States.
Sundar Mahalingam, President of Strategy at HCL Corporation and the Shiv Nadar Foundation said “The collaboration between VidyaGyan, a noble transformative initiative of the Shiv Nadar Foundation, and Illinois Tech is a testament to our shared vision of transforming lives through education. By bridging opportunity gaps for talented first-generation students, we are fostering pathways to excellence and global exposure. This partnership reflects our unwavering commitment to nurturing leaders who will drive meaningful change and create a ripple effect of progress within their communities and beyond. Together, we are enabling access to world-class education and championing inclusion and equity as pillars of sustainable growth.”
Mallik Sundharam, Vice President for Enrollment Management and Student Affairs at Illinois Tech “We are delighted to formalize this partnership with the Shiv Nadar Foundation to support VidyaGyan students. By welcoming these exceptionally talented individuals to our campus, we are enriching our community with unique perspectives of global first-generation students while advancing our mission of expanding access to quality education for all. We look forward to seeing Raj and Vijay thrive at Illinois Tech and to welcoming future cohorts who will follow in their footsteps.”
Both students have excelled at Illinois Tech. Raj Dwivedi is majoring in computer science and has a strong interest in physics, with hopes of advancing into the field of quantum computing. He has been exploring quantum mathematics and is actively seeking opportunities to collaborate with faculty members on campus. Pratap Singh, who is majoring in computer engineering, plans to focus on semiconductors, having authored a research paper on the topic in India. Outside of academics, both students have been enjoying Chicago’s diverse cultural scene—discovering new restaurants, visiting museums, and making new friends on and off campus.
Raj Dwivedi, VidyaGyan graduate, hailing from Unnao in the state of Uttar Pradesh said “Receiving this scholarship is one of the most significant moments in my life. Illinois Tech has such a vibrant community and knowledgeable professors—every time I talk to a new professor, I walk away with a fresh idea. Knowing that the institution sees my potential motivates me to work harder and focus on achieving my future goals. I’m excited to be part of this inspiring community and can’t wait to see where this journey will lead.”
Pratap Singh, VidyaGyan graduate from Mainpuri in Uttar Pradesh said “I would not have been able to study abroad without this scholarship, so I am deeply grateful to the Shiv Nadar Foundation for believing in us. Their confidence fuels my determination to excel and do something truly impactful. I am eager to immerse myself in the global community at Illinois Tech and get the most I can out of this experience.”
MAHE Partners with The/Nudge to Empower 43,500 Jharkhand Households
Bengaluru, 20 February 2025 – Manipal Academy of Higher Education (MAHE) has signed a Memorandum of Understanding with The/Nudge Institute to provide alternative, dignified, comprehensive and sustainable livelihood opportunities for the most excluded households in Jharkhand. Under this MOU, a series of initiatives will be undertaken in identified areas of Jharkhand, by The/Nudge and MAHE, through its constituent unit Manipal TATA Medical College (MTMC), to enable sustainable and diversified livelihoods for women-led households and at the same time provide for primary healthcare requirements.
Starting April 2025, the partnership is expected to impact 43,500 households over the next six years across several districts in Jharkhand, to drive transformative change in the state.
With a focus on making women agents of change, The/Nudge Institute has been supporting the efforts of the Government of Jharkhand to target women from particularly vulnerable tribal groups and those currently engaged in the manufacturing and selling of haria and shift them to more dignified livelihoods. The program enables an interest-free loan to purchase assets, provides 150 weeks of coaching on vegetable cultivation, livestock rearing while linking households to government programs, market services, and livelihood assets.
“The support from MAHE and MTMC underscores our joint commitment to enable the upliftment of rural women in Jharkhand and is a significant milestone in our journey to serve the most excluded households in the region in partnership with the Government of Jharkhand”, said Atul Satija, Founder and CEO, The/Nudge Institute.
Lt. Gen. (Dr.) M. D. Venkatesh, VSM (Retd), Vice Chancellor MAHE said, “We are thrilled to partner with The/Nudge Institute which is looking to scale the evidence-based graduation approach to catalyze long-term, sustained socio-economic growth in the region. Given the long-term commitment of MTMC to the region, this initiative aligns with the vision to reach out to those who are socially and financially excluded and work towards the comprehensive well-being of the excluded households. MAHE through MTMC will participate in various primary health care initiatives, livelihood skill support.”
Birla Fertility & IVF Expands to Mumbai, Plans Four More Centres in the City
Mumbai, 20 February 2025: Birla Fertility & IVF, India’s third-largest IVF network, has launched its first centre in Mumbai, further strengthening its presence in Maharashtra. Conveniently located in Prabhadevi, near Siddhivinayak Temple, the centre ensures easy access to advanced fertility care.
The centre was formally inaugurated by renowned IVF specialist and Chief Guest, Dr. Hrishikesh Pai, in the presence of Birla Fertility & IVF’s Chief Executive Officer, Abhishek Aggrawal; Centre Head, Dr. Navina Singh, and other dignitaries, with a traditional lamp-lighting ceremony.
As part of its expansion strategy in Maharashtra, four more centres are set to open in Mumbai over the next 8–12 months with one existing centre at Nagpur. Beyond Mumbai, new centres are planned in Pune and Nashik, further strengthening access to expert-led fertility care across the region.
Birla Fertility & IVF is part of the CK Birla Group, a USD 3 billion diversified conglomerate with a 150-year legacy. The Group has a strong presence in healthcare, technology, and manufacturing, built on trust, medical excellence, and innovation. With over 50 clinics across 37 cities and 18 states, Birla Fertility & IVF is rapidly expanding, bringing clinically advanced and patient-centric fertility care closer to those who need it.
Infertility is a growing concern, with an estimated 28 million couples in India facing challenges in conceiving. The demand for specialised fertility treatments is rising, yet access to affordable, high-quality reproductive care remains a barrier for many. Birla Fertility & IVF is committed to offering comprehensive fertility solutions, combining advanced treatments with affordability and accessibility.
As part of this commitment, one of the key initiatives focuses on making fertility preservation more financially accessible. Egg freezing, which has traditionally been considered expensive, is now available with structured payment options starting at just INR 1,666 per month. This initiative ensures that individuals can plan their reproductive future with greater confidence and ease.
Abhishek Aggrawal, Chief Executive Officer, Birla Fertility & IVF, said:
“Our mission is to make high-quality, affordable, and comprehensive fertility and reproductive health solutions accessible across India. In addition to fertility treatments, we provide specialised care for PCOS, sexual health concerns, and cervical health, ensuring holistic support at every stage of an individual’s reproductive journey. Our goal of operating 100+ centres with an investment of INR 500 crores in the next few years is well on track.”“Mumbai is a major hub, and this centre is a key milestone in our expansion. With additional centres planned in Pune and Nashik, we are committed to making fertility care more accessible across Maharashtra.”
The National Family Health Survey (2019-21) revealed that 29 of India’s 36 states have a fertility rate below 2. Maharashtra’s fertility rate stands at 1.7, while India’s total fertility rate (TFR) has dropped to 2.0, below the replacement threshold of 2.1. These trends have long-term implications for workforce dynamics and economic growth. Birla Fertility & IVF aims to bridge this gap by providing quality fertility treatment and evidence-based information, empowering individuals to make informed reproductive health decisions.
Dr. Navina Singh, Centre Head – Mumbai, Birla Fertility & IVF, said:
“Infertility is becoming more common in urban areas due to high-stress lifestyles, delayed parenthood, and environmental factors. Every fertility journey is unique and requires a personalised approach. With advanced technology and tailored treatment options, including egg freezing, we are committed to making high-quality fertility care more accessible. This new centre will support individuals in making informed reproductive choices.”
The Mumbai clinic is equipped with state-of-the-art embryology labs and a dedicated team of fertility specialists. It offers a full spectrum of reproductive health services, including IVF, IUI, fertility preservation (egg & sperm freezing), Preimplantation Genetic Testing (PGT), male fertility treatments, advanced genetic screening, and specialised care for PCOS and cervical health.
With a patient-first approach, transparent pricing, and clinically reliable outcomes, Birla Fertility & IVF continues to redefine fertility care in India.
Modern Public School Hosts Indo-Azerbaijani Cultural Exchange Program
20th February 205: Modern Public School (MPS), Shalimar Bagh, New Delhi, recently concluded an enriching seven-day Indo-Azerbaijani cultural exchange program. The program fostered international camaraderie, knowledge-sharing, and cross-cultural appreciation. The school was honoured to host thirteen distinguished educators from Baku, Azerbaijan, on a transformative journey that deepened mutual understanding and strengthened educational ties between the two nations.
The exchange commenced with a warm, traditional Indian welcome at the Principal’s residence, reflecting the philosophy of Atithi Devo Bhava—treating guests with divine reverence. Throughout their stay, the Azerbaijani delegation actively engaged in Modern Public School’s academic environment, participating in classroom observations, delivering guest lectures, and recognizing outstanding student achievements during a special assembly. Their educational immersion extended to prestigious institutions such as Delhi University and Jawaharlal Nehru University, where they explored India’s higher education landscape.
Beyond academia, the delegates explored India’s spiritual and cultural heritage, visiting iconic sites such as Gurudwara Nanak Piao, Akshardham Temple, and Nizamuddin Dargah. They also experienced the vibrancy of Indian festivities by participating in Phoolon ki Holi and celebrating Lohri around a ceremonial bonfire. The delegation also toured Rashtrapati Bhawan and Bharat Darshan Park, which offered them more profound insights into India’s governance and cultural diversity.
Their journey extended to experiencing Delhi’s dynamic lifestyle at the bustling Surajkund Mela, Select City Mall, and the traditional markets of Lajpat Nagar. A visit to Agra provided an awe-inspiring encounter with the architectural grandeur of the Taj Mahal and Agra Fort.
The cultural exchange culminated in a heartfelt farewell dinner at the Principal’s residence, graced by His Excellency Elchin Huseynli, Ambassador of Azerbaijan to India, who lauded the initiative for fostering international goodwill and educational collaboration. A certificate presentation ceremony marked the successful completion of this cross-cultural journey, solidifying the enduring friendship between the Modern Public School and the Azerbaijani educators.
Reflecting on the exchange, the Principal of Modern Public School, Dr. Alka Kapur, expressed, “This program has been an incredible opportunity to bridge cultures, celebrate diversity, and create lifelong friendships. We are proud to be a part of this meaningful global initiative and look forward to future collaborations with Azerbaijan and other friendly countries to India for mutual cultural and educational growth.”
This cultural immersion not only reshaped perceptions but also reinforced the power of education in uniting nations. As the program concluded, it was evident that the bonds formed during this journey would continue to thrive, paving the way for more global exchanges.
ZEE Entertainment secures high S&P Global ESG score outperforms the industry
Mumbai, 20th February 2025: ZEE Entertainment Enterprises Ltd. (ZEE), the leading Media & Entertainment powerhouse, has earned an exceptional ESG score of 44 in the annual S&P Global Corporate Sustainability Assessment (CSA). The industry- leading score reaffirms the Company’s commitment towards implementing the best practices in sustainability across Environment, Social and Governance (ESG).
This achievement places ZEE significantly ahead of the industry average score of 20 and ranks it amongst the top 10% of global players within the sector, underscoring the Company’s dedication to responsible business practices and sustainable growth. The Company witnessed a significant improvement of 16 points in its score from 2023, placing it in the 93rd percentile across the global Media, Movies & Entertainment industry.
The Company has undertaken significant interventions across the core ESG domains to demonstrate exceptional standards in Corporate Responsibility. ZEE excelled in various aspects of the CSA score including Transparency & Reporting, where it ranked in the top 100th percentile; and Business Ethics, Information Security/ Cybersecurity & System Availability, Water, Labour Practice, Human rights and Customer relations, where it ranked above the 90th percentile.
ZEE’s high ESG score reflects its robust initiatives in various areas that include management of material ESG risks, opportunities and impact that were measured through a combination of company disclosures, media and stakeholder analysis, modelling approaches and in-depth company engagement.
Commenting on the noteworthy achievement, Mr. Punit Goenka, Chief Executive Officer, ZEE Entertainment Enterprises Ltd. said, “At ZEE, we believe in staying ahead of the curve by consistently delivering industry-beating performance across all aspects. The high ESG score achieved by the Company in the renowned S&P Global assessment is yet another firm testament to our commitment of implementing the best practices in the environmental, social and governance domains. As a responsible corporate citizen, sustainable growth remains key to driving long-term success and our efforts remain focused towards enhancing environmental sustainability, promoting social equity and maintaining strong governance frameworks. As we take concerted steps to achieve our targeted aspirations, prioritizing key initiatives in the realm of ESG is a core focus area, ensuring that ZEE continues to deliver industry-leading performance in entertainment as well as corporate responsibility.”
With a robust ESG strategy for the future, ZEE aims to attain industry leadership in sustainability and responsible business conduct. The Company’s exceptional ESG performance during the year, reflects its broader vision to generate higher long-term value for all its stakeholders while simultaneously contributing towards positive societal development.
Vietjet Offers 20% Discount on Business & Skyboss Fares for Feb 20
(Mumbai, February 20, 2025) – Vietjet is offering an exclusive discount of up to 20% (excluding taxes and fees) on Business and SkyBoss fares across its entire flight network. This special promotion is available only on February 20, 2025, for travel dates from March 5 to May 29, 2025 (excluding national holidays and peak travel periods).
Vietjet’s growing flight network offers non-stop flights from New Delhi, Mumbai, Ahmedabad, and Kochi to Vietnamese key hubs, including Hanoi, Ho Chi Minh City, and Da Nang.
Starting March 2025, Vietjet will also launch two new direct services linking Bangalore and Hyderabad to Ho Chi Minh City, bringing the total to 10 routes with 78 weekly flights between India and Vietnam. With Vietjet’s affordable fares and extensive connections, Indian travellers can easily transit through Vietnam to popular destinations, including Bali, Kuala Lumpur, Singapore, and major Australian cities.
Vietjet consistently ranks among the best and safest low-cost carriers worldwide. The airlline has recently been honored with three international HR awards at the 33rd edition of the World HRD Congress in Mumbai, India, including “Dream Company to Work For,” “Best Corporate Social Responsibility Practices,” and “Global Best Employer Brand.”
As a new-age airline, Vietjet is recognized for its effective human resource management system, competitive employee benefits, and dynamic working environment. Operating a new and fuel-efficient fleet, the airline pursues sustainable growth in alignment with its ESG goals. Vietjet also invests in developing aviation human resources through comprehensive international training programs at Vietjet Aviation Academy (VJAA)
Abans Financial Services Advises Vaishali Pharma on Kesar Pharma Acquisition
Mumbai, February 20, 2025- Vaishali Pharma announced its acquisition of a majority stake in Kesar Pharma Limited. Abans Financial Services Limited served as the exclusive financial advisor for this transaction.
Founded in 2008, Vaishali Pharma Limited specializes in pharmaceutical APIs, formulations, surgical products, and nutraceuticals. It became public in 2017 and have international presence with headquartered situated in Mumbai.
Kesar Pharma Limited, operating WHO-GMP certified facilities, specializes in manufacturing, contract manufacturing, and private label production of diverse pharmaceutical formulations, including tablets, syrup and ointments.
The cash and stock deal combines Vaishali Pharma’s market presence with Kesar Pharma’s manufacturing expertise and R&D. With this acquisition, Vaishali Pharma gains a manufacturing facility that complies with WHO-GMP and other international regulatory guidelines. Leveraging Kesar’s manufacturing and supply chain strengths alongside Vaishali’s global reach, the merged entity is poised for accelerated growth in domestic and international markets.
Atul Vasani, Chairman of Vaishali Pharma, stated, “This acquisition marks a significant milestone for both companies. By joining forces with Kesar Pharma, we aim to maximize the utilization of its advanced manufacturing facilities while maintaining the highest industry standards. This strategic move will allow us to scale our operations, enhance our global reach, and continue delivering high-quality, affordable healthcare solutions. We are confident that this partnership will create long-term value for our stakeholders and help us achieve our ambitious growth targets.
Further, we extend our gratitude to Investment Banking team of Abans for their comprehensive support from deal conceptualization and structuring, bringing a unique value proposition and seamless execution of all facets of the transaction process resulting in this successful acquisition.”
Nirbhay Vassa, Whole Time Director and CFO, Abans Financial Services Limited said, “Abans is pleased to announce the strategic acquisition of Kesar Pharma Limited by Vaishali Pharma Limited. This strategic acquisition brings together two organizations anchored in similar values. We remain excited about its future prospects, given a large global market opportunity. We wish the companies success in their continued quest to create sustainable value for all their stakeholders.”
Ketur Shah, Investment Banker at Abans Financial Services Limited added, “Abans was privileged to partner with Vaishali Pharma, supporting their acquisition, business strategy and growth needs. We are pleased to have guided them through the acquisition of a majority stake in Kesar Pharma Limited. We wish Vaishali and Kesar Pharma Limited continued success in their next phase of growth.”
This acquisition marks a pivotal moment for Vaishali Pharma and Kesar Pharma, strengthening their market position and unlocking new growth opportunities. The combined entity is poised to drive innovation, expand product offerings, and enhance operational efficiencies by integrating its expertise, resources, and global networks.
With a shared commitment to quality, compliance, and customer satisfaction, this strategic move reinforces its mission to deliver high-quality, affordable healthcare solutions worldwide. As Vaishali Pharma and Kesar Pharma move forward together, with Abans Financial Services playing a key advisory role, they remain dedicated to creating long-term value for stakeholders and advancing their presence in the pharmaceutical industry.